Hormonal correlates and causes of sexual desire: A review

Canadian Journal of Human Sexuality

Volumn 8, Issue 1, 1999, Pages 1-16

  Regan, Pamela C ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Hormones; Sex hormones; Sexual desire

Indexed keywords

ANDROGEN; ESTROGEN; PROGESTERONE; PROLACTIN;

AROUSAL; FEMALE; HORMONAL REGULATION; HUMAN; LIBIDO; MALE; REVIEW; SEXUAL BEHAVIOR;

EID: 0032766687     PISSN: 11884517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (152)

1. Abplanalp, J.M., Rose, R.M., Donnelly, A.F., & Livingstone-Vaughan, L. (1979). Psycho-endocrinology of the menstrual cycle: II. The relationship between enjoyment of activities, moods and reproductive hormones. Psychosomatic Medicine, 41, 605-615.
2. Alder, E.M., Cook, A., Davidson, D., West, C., & Bancroft, J. (1986). Hormones, mood and sexuality in lactating women. British Journal of Psychiatry, 148, 74-79.
3. Alexander, G.M., & Sherwin, B.B. (1993). Sex steroids, sexual behavior, and selective attention for erotic stimuli in women using oral contraceptives. Psychoneuroendrocrinology, 18, 91-102.
4. Appelt, H., & Strauss, B. (1986). The psychoendocrinology of female sexuality: A research project. The German Journal of Psychology, 10, 143-156.
5. Arver, S., Dobs, A.S., Meikle, A.W., Allen, R.P., Sanders, S.W., & Mazer, N.A. (1996). Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. The Journal of Urology, 155, 1604-1608.
6. Baird, D.T. (1976). Oestrogens in clinical practice. In J.A. Loraine & E.T. Bell (Eds.), Hormone Assays and Their Clinical Application, 4th Ed. (pp. 408-446). Edinburgh: Churchill Livingstone.
7. Bakke, J.L. (1965). A double-blind study of a progestin-estrogen combination in the management of the menopause. Pacific Medicine & Surgery, 73, 200-205.
8. Bancroft, J. (1984). Hormones and human sexual behavior. Journal of Sex & Marital Therapy, 10, 3-21.
9. Bancroft, J. ( 1988). Sexual desire and the brain. Sexual and Marital Therapy, 3, 11-27.
10. Bancroft, J., O'Carroll, R., McNeilly, A., & Shaw, R.W. (1984). The effects of bromocriptine on the sexual behavior of a hyperprolactinaemic man: A controlled case study. Clinical Endocrinology, 21, 131-137.
11. Bancroft, J., Sanders, D., Davidson, D., & Warner, P. (1983). Mood, sexuality, hormones, and the menstrual cycle. III. Sexuality and the role of androgens. Psychosomatic Medicine, 45, 509-516.
12. Bancroft, J., Tennent, G., Loucas, K., & Cass, J. (1974). The control of deviant sexual behaviour by drugs: I. Behavioral changes following oestrogens and antiandrogens. British Journal of Psychiatry, 125, 310-315.
13. Benedek, T., & Rubenstein, B.B. (1939a). The correlations between ovarian activity and psychodynamic processes: I. The ovulative phase. Psychosomatic Medicine, 1, 245-270.
14. Benedek, T., & Rubenstein, B.B. (1939b). The correlations between ovarian activity and psychodynamic processes: II. The menstrual phase. Psychosomatic Medicine, 1, 461-485.
15. Berlin, F.S., & Meinecke, C.F. (1981). Treatment of sex offenders with antiandrogenic medication: Conceptualization, review of treatment modalities, and preliminary findings. American Journal of Psychiatry, 138, 601-607.
16. Briggs, M., & Briggs, M. (1972). Plasma hormone concentrations in women receiving steroid contraceptives. Journal of Obstetrics & Gynaecology of the British Commonwealth, 79, 946-950.
17. Briggs, M., & Briggs, M.H. (1971). Treatment of male hypersexual conditions by a non-oestrogenic antiandrogen. Medical Journal of Zambia, 5, 125-129.
18. Brincat, M., Studd, J.W.W., O'Dowd, T., Magos, A., Cardozo, L.D., Wardle, P.J., & Cooper, D. (1984). Subcutaneous hormone implants for the control of climacteric symptoms: A prospective study. The Lancet, January, 16-18.
19. Brown, W.A., Monti, P.M., & Corriveau, D.P. (1978). Serum testosterone and sexual activity and interest in men. Archives of Sexual Behavior, 7, 97-103.
20. Buckman, M.T., & Kellner, R. (1985). Reduction of distress in hyperprolactinemia with bromocriptine. American Journal of Psychiatry, 142, 242-244.
21. Burger, H.G., Hailes, J., Menelaus, M., Nelson, J., Hudson, B., & Balazs, N. (1984). The management of persistent menopausal symptoms with oestradiol-testosterone implants: Clinical, lipid and hormonal results. Maturitas, 6, 351-358.
22. Buss, D.M., & Schmitt, D.P. (1993). Sexual strategies theory: An evolutionary perspective on human mating. Psychological Review, 100, 204-232.
23. Campbell, B.C., & Udry, J.R. (1994). Implications of hormonal influences on sexual behavior for demographic models of reproduction. Annals of the New York Academy of Sciences, 709, 117-127.
24. Campbell, S. (1976). Double-blind psychometric studies on the effects of natural estrogens on post-menopausal women. In S. Campbell (Ed.), The Management of the Menopausal and Post-Menopausal Years (pp. 149-158). Baltimore, MD: University Park Press.
25. Campbell, S., & Whitehead, M. (1977). Oestrogen therapy and the menopausal syndrome. Clinical Obstetrics and Gynecology, 4, 31-47.
26. Cardozo, L., Gibb, D.M.F., Tuck, S.M., Thom, M.H., Studd, J.W.W., & Cooper, D.J. (1984). The effects of subcutaneous hormone implants during the climacteric. Maturitas, 5, 177-184.
27. Carney, A., Bancroft, J., & Mathews, A. (1978). Combination of hormonal and psychological treatment for female sexual unresponsiveness: A comparative study. British Journal of Psychiatry, 133, 339-346.
28. Carter, J.N., Tyson, J.E., Tolis, G., Van Vliet, S., Faiman, C., & Friesen, H.G. (1978). Prolactin-secreting tumors and hypogonadism in 22 men. New England Journal of Medicine, 299, 847-852.
29. Cittadini, E., & Barreca, P. (1977). Use of antiandrogens in gynecology. In L. Martini & M. Motta (Eds.), International Symposium on Androgens and Antiandrogens, Milan, 1976 (pp. 309-319). New York: Raven Press.
30. Coope, J. (1976). Double-blind cross-over study of estrogen replacement. In S. Campbell (Ed.), The Management of the Menopausal and Post-Menopausal Years (pp. 159-168). Baltimore, MD: University Park Press.
31. Cooper, A.J. (1986). Progestogens in the treatment of male sex offenders: A review. Canadian Journal of Psychiatry, 31, 73-79.
32. Cooper, A.J. (1995). Review of the role of two antilibidinal drugs in the treatment of sex offenders with mental retardation. Mental Retardation, 33, 42-48.
33. Cooper, A.J., Ismail, A.A.A., Phanjoo, A.L., & Love, D.L. (1972). Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality. British Journal of Psychiatry, 120, 59-63.
34. Cooper, A.J., Sandhu, S., Losztyn, S., & Cernovsky, Z. (1992). A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Canadian Journal of Psychiatry, 37, 687-693.
35. Cremoncini, C., Vignati, E., & Libroia, A. (1977). Treatment of hirsutism and acne in women with 2 combinations of CPA and EE. Acta Europaea Fertilitatis, 7, 299-314.
36. Davis, S.R. (1998). The clinical use of androgens in female sexual disorders. Journal of Sex & Marital Therapy, 24, 153-163.
37. Dennerstein, L., & Burrows, G.D. (1982). Hormone replacement therapy and sexuality in women. Clinics in Endocrinology and Metabolism, 11, 661-679.
38. Dennerstein, L., Burrows, G.D., Wood, C., & Hyman, G. (1980). Hormones and sexuality: The effect of estrogen and progestogen. Obstetrics and Gynecology, 56, 316-322.
39. Dennerstein, L., Gotts, G., Brown, J.B., Morse, C.A., Farley, T.M., & Pinol, A. (1994). The relationship between the menstrual cycle and female sexual interest in women with PMS complaints and volunteers. Psychoneuroendocrinology, 19, 293-304.
40. Dornan, W.A., & Malsbury, C.W. (1989). Neuropeptides and male sexual behavior. Neuroscience & Biobehavioral Reviews, 13, 1-15.
41. Dow, M.G.T., & Gallagher, J. (1989). A controlled study of combined hormonal and psychological treatment for sexual unresponsiveness in women. British Journal of Clinical Psychology, 28, 201-212.
42. Drago, F. (1984). Prolactin and sexual behavior: A review. Neuroscience & Biobehavioral Reviews, 8, 433-439.
43. Dunn, J.F., Nisula, B.C., & Rodbard, D. (1981). Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. The Journal of Clinical Endocrinology & Metabolism, 53, 58-68.
44. Eskin, B.A., Aspinall, A.R., & Segrave-Daly, S.L. (1985). Effects of hormone-secreting tumors on libido. Medical Aspects of Human Sexuality, 19, 50-66.
45. Faglia, G., Beck-Peccoz, P., Travaglini, P., Ambioso, B., Rondena, M., Paracchi, A., Spada, A., Welser, G., & Bouzin, A. (1977). Functional studies in hyperprolactinaemic states. In P.G. Crosignani & C. Robyn (Eds.), Prolactin and Human Reproduction (pp. 225-238). London: Academic Press.
46. Fava, G.A., Fava, M., Kellner, R., Serafini, E., & Mastrogiacomo, I. (1981). Depression, hostility and anxiety in hyperprolactinemic amenorrhea. Psychotherapy and Psychosomatics, 36, 122-128.
47. Ferracuti, F., & Bartilotti, R. (1975). Technical and legal aspects in the pharmacologic treatment of sex offenders. In M. Sandler & G.L. Gessa (Eds.), Sexual Behavior: Pharmacology and Biochemistry (pp. 205-208). New York: Raven Press.
48. Field, L.H. (1973). Benperidol in the treatment of sexual offenders. Medicine, Science and the Law, 13, 195-196.
49. Field, L.H., & Williams, M. (1970). The hormonal treatment of sexual offenders. Medicine, Science and the Law, 10, 27-34.
50. Filler, W., & Drezner, N. (1944). The results of surgical castration in women under forty. American Journal of Obstetrics and Gynecology, 47, 122-124.
51. Fotherby, K. (1984). Biosynthesis of the oestrogens. In H.L.J. Makin (Ed.), Biochemistry of Steroid Hormones, 2nd Ed. (pp. 207-229). Oxford: Blackwell Scientific Publications.
52. Franks, S., Jacobs, H.S., Martin, N., & Nabarro, J.D.N. (1978). Hyperprolactinaemia and impotence. Clinical Endocrinology, 8, 277-287.
53. Friesen, H.G., Tolis, G., Shiu, R., & Hwang, R. (1973). Studies on human prolactin: Chemistry, radio receptor assay and clinical significance. In J.L. Pasteels & C. Robyn (Eds.), Human Prolactin (pp. 11-23). Amsterdam: Exerpta Medica.
54. Furuhjelm, M., Karlgren, E., & Carlstrom, K. (1984). The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstetricia et Gynecologica Scandinavica, 63, 655-661.
55. Glickman, S.P., Rosenfield, R.L., Bergenstal, R.M., & Helke, J. (1982). Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. The Journal of Clinical Endocrinology & Metabolism, 55, 251-257.
56. Golla, F.L., & Hodge, S.R. (1949). Hormone treatment of the sexual offender. The Lancet, 1, 1006-1007.
57. Goodman, R.H., Molitch, M.E., Post, K.D., & Jackson, I.M.D. (1980). Prolactin secreting adenomas in the male. In R.H. Goodman, M.E. Molitch, K.E. Post, & I.M.D. Jackson (Eds.), The Pituitary Aadenoma (pp. 91-108). New York: Plenum Medical Book Press.
58. Gooren, L.J. (1987). Androgen levels and sex functions in testosterone-treated hypogonadal men. Archives of Sexual Behavior, 16, 463-473.
59. Green, S.E., & Mosher, D.L. (1985). A causal model of sexual arousal to erotic fantasies. The Journal of Sex Research, 21, 1-23.
60. Greenblatt, R.B., McCall, E.F., & Torpin, R. (1941). Histologic changes in ovary following gonadotropin administration. American Journal of Obstetrics and Gynecology, 42, 983-996.
61. Greenblatt, R.B., Mortara, F., & Torpin, R. (1942). Sexual libido in the female. American Journal of Obstetrics and Gynecology, 44, 658-663.
62. Halpern, C.T., Udry, J.R., Campbell, B., Suchindran, C., & Mason, G.A. (1994). Testosterone and religiosity as predictors of sexual attitudes and activity among adolescent males: A biosocial model. Journal of Biosocial Science, 26, 217-234.
63. Hames, C.T. (1980). Sexual needs and interests of postpartum couples. Journal of Obstetric Gynecologic and Neonatal Nursing, 9, 313-315.
64. Hammerstein, J., Meckies, J., Leo-Rosberg, I., Moltz, L., & Zielske, F. (1975). Use of cyproterone acetate in the treatment of acne, hirsutism and virilism. The Journal of Steroid Biochemistry, 6, 827-836.
65. Heller, C.G., Laidlaw, W.M., Harvey, H.T., & Nelson, W.O. (1958). Effects of progestational compounds on the reproductive processes of the human male. Annals of the New York Academy of Sciences, 71, 649-665.
66. Hucker, S., Langevin, R., & Bain, J. (1988). A double blind trial of sex drive reducing medication in pedophiles. Annals of Sex Research, 1, 227-242.
67. Huffer, V., Levin, L., & Aronson, H. (1970). Oral contraceptives: Depression and frigidity. The Journal of Nervous and Mental Disease, 151, 35-41.
68. Itoh, N., Kumamoto, Y., Akagashi, K., Maruta, H., Tsukamoto, T., Umehara, T., Mikuma, N., Yamaguchi, Y., Nanbu, A., & Suzuki, N. (1991). The assessment of bioavailable androgen levels from the serum free testosterone level. Nippon Naibunpi Gakkai Zasshi, 67, 23-22.
69. Kane, F.J., Lipton, M.A., & Ewing, J.A. (1969). Hormonal influences in female sexual response. Archives of General Psychiatry, 20, 202-209.
70. Kaplan, H.S. (1979). Disorders of Sexual Desire and Other New Concepts and Techniques in Sex Therapy. New York: Simon & Schuster.
71. Kaplan, H.S. (1992). A neglected issue: The sexual side effects of current treatments for breast cancer. Journal of Sex & Marital Therapy, 18, 3-19.
72. Kaplan, H.S., & Owett, T. (1993). The female androgen deficiency syndrome. Journal of Sex & Marital Therapy, 19, 3-24.
73. Kayner, C.E., & Zagar, J.A. (1983). Breast-feeding and sexual response. Journal of Family Practice, 17, 69-73.
74. Kellner, R., Buckman, M.T., Fava, G.A., & Pathak, D. (1984). Hyperprolactinemia, distress, and hostility. American Journal of Psychiatry, 141, 759-763.
75. Kennedy, B.J. (1973). Effect of massive doses of sex hormones on libido. Medical Aspects of Human Sexuality, 7, 67-78.
76. Kenny, J.A. (1973). Sexuality of pregnant and breastfeeding women. Archives of Sexual Behavior, 2, 215-229.
77. Kenrick, D.T., Gutierres, S.E., & Goldberg, L.L. (1989). Influence of popular erotica on judgments of strangers and mates. Journal of Experimental Social Psychology, 25, 159-167.
78. Khan-Dawood, F.S., Choe, J.K., & Dawood, M.Y. (1984). Salivary and plasma bound and "free" testosterone in men and women. The American Journal of Obstetrics and Gynecology, 148, 441-445.
79. Kiersch, T.A. (1990). Treatment of sex offenders with Depo-Provera. Bulletin of the American Academy of Psychiatry and the Law, 18, 179-187.
80. Koppelman, M.C.S., Parry, B.L., Hamilton, J.A., Alagna, S.W., & Loriaux, D.L. (1987). Effect of bromocriptine on mood, affect and libido in hyperprolactinemia. American Journal of Psychiatry, 144, 1037-1041.
81. Kravitz, H.M., Haywood, T.W., Kelly, J., Wahlstrom, C., Liles, S., & Cavanaugh, J.L. (1995). Medroxyprogesterone treatment for paraphiliacs. Bulletin of the American Academy of Psychiatry and the Law, 23, 19-33.
82. Kwan, M., Greenleaf, W.J., Mann, J., Crapo, L., & Davidson, J.M. (1983). The nature of androgen action on male sexuality: A combined laboratory-self-report study on hypogonadal men. The Journal of Clinical Endocrinology & Metabolism, 57, 557-562.
83. Labrie, F., DuPont, A., Belanger, A., St. Arnaud, R., Giguere, M., Lacourciere, Y., Emond, J., & Monfette, G. (1986). Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocrine Reviews, 7, 67-74.
84. Laschet, V., & Laschet, L. (1969). Three years' clinical results with cyproterone acetate in the inhibiting regulation of male sexuality. Acta Endocrinologica Supplementum, 138, 103.
85. Leiblum, S., Bachmann, G., Kemmann, E., Colburn, D., & Schwartzman, L. (1983). Vaginal atrophy in the postmenopausal woman: The importance of sexual activity and hormones. Journal of the American Medical Association, 249, 2195-2198.
86. Leiblum, S.R., & Rosen, R.C. (1988). Introduction: Changing perspectives on sexual desire. In S.R. Leiblum & R.C. Rosen (Eds.), Sexual Desire Disorders (pp. 1-17). New York: Guilford Press.
87. Legros, J.J., Chiodera, P., & Servalis, J. (1980). Hormones and sexual impotence. In D. de Wied & P.A. van Keep (Eds.), Hormones and the Brain (pp. 205-217). Lancaster: MTP Press.
88. Levine, S.B. (1987). More on the nature of sexual desire. Journal of Sex & Marital Therapy, 13, 35-44.
89. Lundberg, P.O., & Hulter, B. (1991). Sexual dysfunction in patients with hypothalamo-pituitary disorders. Experimental and Clinical Endocrinology, 98, 81-88.
90. Maletzky, B.M. (1991). The use of medroxyprogesterone acetate to assist in the treatment of sexual offenders. Annals of Sex Research, 4, 117-129.
91. Masters, W.H., Johnson, V.E., & Kolodny, R.C. (1982). Human Sexuality. Boston, MA: Little, Brown and Company.
92. Masters, W.H., Johnson, V.E., & Kolodny, R.C. (1994). Heterosexuality. New York, NY: HarperCollins.
93. Mathews, A., Whitehead, A., & Kellet, J. (1983). Psychological and hormonal factors in the treatment of female sexual dysfunction. Psychological Medicine, 13, 83-92.
94. Mazenod, B., Pugeat, M., & Forest, M.G. (1988). Hormones, sexual function and erotic behavior in women. In J.M.A. Sitsen (Ed.), Handbook of Sexology. Vol. 6: The Pharmacology and Endocrinology of Sexual Function (pp. 316-351). Amsterdam: Elsevier Science Publishers B.V.
95. McCauley, E., & Ehrhardt, A.A. (1976). Female sexual response: Hormonal and behavioral interactions. Primary Care, 3, 455-476.
96. McCullough, R.C. (1974). Rhythms of sexual desire and sexual activity in the human female. Dissertation Abstracts International, 34, 4669B-4670B.
97. Money, J. (1970). Use of an androgen-depleting hormone in the treatment of male sex offenders. The Journal of Sex Research, 6, 165-172.
98. Mounib, N., Sultan, C., Bringer, J., Hedon, B., Nicolas, J.C., Cristol, P., Bressot, N., & Descomps, B. (1988). Correlations between free plasma estradiol and estrogens determined by bioluminescence in saliva, plasma, and urine during spontaneous and FSH stimulated cycles in women. The Journal of Steroid Biochemistry, 31, 861-865.
99. Muller, P., Musch, K., & Wolf, A.S. (1979).Prolactin: Variables of personality and sexual behavior. In L. Zichella & P. Pancheri (Eds.), Psychoneuroendocrinology in Reproduction (pp. 357-372). North Holland: Elsevier.
100. Myers, B.A. (1991). Treatment of sexual offenses by persons with developmental disabilities. American Journal of Mental Retardation, 95, 563-569.
101. Naik, S., & Pennington, G.W. (1981). Female gonadal function: The ovary. In G.W. Pennington & S. Naik (Eds.), Hormone Analysis: Methodology and Clinical Interpretation, Vol. 2 (pp. 27-61). Boca Raton, FL: CRC Press, Inc.
102. Nathorst-Boos, J., von Schoultz, B., & Carlstrom, K. (1993). Elective ovarian removal and estrogen replacement therapy - effects on sexual life, psychological well-being and androgen status. Journal of Psychosomatic Obstetrics and Gynaecology, 14, 283-93.
103. Neumann, F., & Kalmus, J. (1991). Cyproterone acetate in the treatment of sexual disorders: Pharmacological base and clinical experience. Experimental and Clinical Endocrinology, 98, 71-80.
104. Nutter, D.E., & Condron, M.K. (1983). Sexual fantasy and activity patterns of females with inhibited sexual desire versus normal controls. Journal of Sex & Marital Therapy, 9, 276-282.
105. Nutter, D.E., & Condron, M.K. (1985). Sexual fantasy and activity patterns of males with inhibited sexual desire and males with erectile dysfunction versus normal controls. Journal of Sex & Marital Therapy, 11, 91-98.
106. O'Carroll, R., & Bancroft, J. (1984). Testosterone therapy for low sexual interest and erectile dysfunction in men: A controlled study. British Journal of Psychiatry, 145, 146-151.
107. O'Carroll, R., Shapiro, C., & Bancroft, J. (1985). Androgens, behaviour and nocturnal erection in hypogonadal men: The effects of varying the replacement dose. Clinical Endocrinology, 23, 527-538.
108. Pennington, G.W., Naik, S., & Bevan, B.R. (1981). The pituitary gland. In G.W. Pennington & S. Naik (Eds.), Hormone Analysis: Methodology and Clinical Interpretation, Vol. 1 (pp. 119-156). Boca Raton, FL: CRC Press, Inc.
109. Persky, H., Dreisbach, L., Muler, W.R., O'Brien, C.P., Khan, M.A., Lief, H.I., Charney, N., & Strauss, D. (1982). The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosomatic Medicine, 44, 305-319.
110. Petak, S.M., Baskin, H.J., Bergman, D.A., Dickey, R.A., & Nankin, H.A. (1998). AACE clinical practice guidelines for the evaluation and treatment of hypogonadism in adult male patients. American Association of Clinical Endocrinologists.
111. Rabkin, J.G., Rabkin, R., & Wagner, G. (1995). Testosterone replacement therapy in HIV illness. General Hospital Psychiatry, 17, 37-42.
112. Regan, P.C. (1996). Rhythms of desire: The association between menstrual cycle phases and female sexual desire. The Canadian Journal of Human Sexuality, 5, 145-156.
113. Regan, P.C. (1998). Of lust and love: Beliefs about the role of sexual desire in romantic relationships. Personal Relationships, 5, 139-157.
114. Regan, P.C., & Berscheid, E. (1995). Gender differences in beliefs about the causes of male and female sexual desire. Personal Relationships, 2, 345-358.
115. Regan, P.C., & Berscheid, E. (1996). Beliefs about the state, goals, and objects of sexual desire. Journal of Sex & Marital Therapy, 22, 110-120.
116. Regan, P.C., & Berscheid, E. (1997). Gender differences in characteristics desired in a potential sexual and marriage partner. Journal of Psychology and Human Sexuality, 9, 25-37.
117. Regan, P.C., & Berscheid, E. (1999). Lust: What We Know About Human Sexual Desire. Newbury Park, CA: Sage.
118. Riley, A.J. (1984). Prolactin and female sexual function. British Journal of Sexual Medicine, 11, 14-17.
119. Rosenfield, R.L. (1990). Hyperandrogenism inperipubertal girls. The Pediatric Clinics of North America, 37, 1333-1358.
120. Rousseau, L., Couture, M., Dupont, A., Labrie, F., & Couture, N. (1990). Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Canadian Journal of Psychiatry, 35, 338-341.
121. Rousseau, L., DuPont, A., Labrie, F., & Couture, M. (1988). Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration. Archives of Sexual Behavior, 17, 87-98.
122. Rubin, R.T., Gouin, P.R., Lubin, A., Poland, R.E., & Pirke, K.M. (1976). Nocturnal increase of plasma testosterone in men: Relation to gonadotropins and prolactin. Journal of Clinical Endocrinology and Metabolism, 40, 1027-1033.
123. Sadowsky, M., Antonovsky, H., Sobel, R., & Maoz, B. (1993). Sexual activity and sex hormone levels in aging men. International Psychogeriatrics, 5, 181-186.
124. Salmimies, P., Kockott, G., Pirke, K.M., Vogt, H.J., & Schill, W.B. (1982). Effects of testosterone replacement on sexual behavior in hypogonadal men. Archives of Sexual Behavior, 11, 345-353.
125. Salmon, U.J., & Geist, S.H. (1943). Effect of androgens upon libido in women. Journal of Clinical Endocrinology, 3, 235-238.
126. Schreiner-Engel, P., Schiavi, R.C., Smith, J., & White, D. (1981). Sexual arousability and the menstrual cycle. Psychosomatic Medicine, 43, 199-214.
127. Schreiner-Engel, P., Schiavi, R.C., White, D., & Ghizzani, A. (1989). Low sexual desire in women: The role of reproductive hormones. Hormones and Behavior, 23, 221-234.
128. Schwartz, M.F., Bauman, J.E., & Masters, W.H. (1982). Hyperprolactinemia and sexual disorders in men. Biological Psychiatry, 17, 861-876.
129. Sherwin, B.B. (1985). Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women. Maturitas, 7, 225-233.
130. Sherwin, B.B. (1988). A comparative analysis of the role of androgen in human male and female sexual behavior: Behavioral specificity, critical thresholds, and sensitivity. Psychobiology, 16, 416-425.
131. Sherwin, B.B. (1994). Sex hormones and psychological functioning in postmenopausal women. Experimental Gerontology, 29, 423-430.
132. Sherwin, B.B., Gelfand, M.M., & Brender, W. (1985). Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause. Psychosomatic Medicine, 47, 339-351.
133. Skakkebaek, N.E., Bancroft, J., Davidson, D.W., & Warner, P. (1981). Androgen replacement with oral testosterone undecanoate in hypogonadal men: A double blind controlled study. Clinical Endocrinology, 14, 49-61.
134. Slob, A.K., van der Werff ten Bosch, J.J., van Hall, E.V., de Jong, F.H., Weijmar Schulte, W.C.M., & Eikelboom, F.A. (1993). Psychosexual functioning in women with complete testicular feminization: Is androgen replacement therapy preferable to estrogen? Journal of Sex & Marital Therapy, 19, 201-209.
135. Stuart, F.M., Hammond, D.C., & Pett, M.A. (1987). Inhibited sexual desire in women. Archives of Sexual Behavior, 16, 91-106.
136. Studd, J.W.W., Collins, W.P., Chakravarti, S., Newton, J.R., Oram, D., & Parsons, A. (1977). Oestradiol and testosterone implants in the treatment of psychosexual problems in the postmenopausal woman. British Journal of Obstetrics & Gynaecology, 84, 314-315.
137. Symmers, W. St. C. (1968). Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. British Medical Journal, 2, 83-85.
138. Tennent, G., Bancroft, J., & Cass, J. (1974). The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine, and placebo. Archives of Sexual Behavior, 3, 261-271.
139. Udry, J.R., Billy, J.O., Morris, N.M., Groff, T.R., & Raj, M.H. (1985). Serum androgenic hormones motivate sexual behavior in adolescent boys. Fertility and Sterility, 43, 90-94.
140. Umstot, E.S., Baxter, J.E., & Andersen, R.N. (1985). A theoretically sound and practical equilibrium dialysis method for measuring percentage of free testosterone. The Journal of Steroid Biochemistry, 22, 639-648.
141. Verhulst, J., & Heiman, J.R. (1979). An interactional approach to sexual dysfunctions. American Journal of Family Therapy, 7, 19-36.
142. Wade, C., & Cirese, S. (1991). Human Sexuality (2nd ed.). San Diego, CA: Harcourt Brace Jovanovich, Publishers.
143. Walsh, J.P., & Pullan, P.T. (1997). Hyperprolactinaemia in males: A heterogeneous disorder. Australian and New Zealand Journal of Medicine, 27, 385-390.
144. Warner, P., & Bancroft, J. (1988). Mood, sexuality, oral contraceptives and the menstrual cycle. Journal of Psychosomatic Research, 32, 417-427.
145. Waterman, G.S., Dahl, R.E., Birmaher, B., Ambrosini, P., Rabinovich, H., Williamson, D., Novacenko, H., Nelson, B., Puig-Antich, J., & Ryan, N.D. (1994). The 24-hour pattern of prolactin secretion in depressed and normal adolescents. Biological Psychiatry, 35, 440-445.
146. Waxenberg, S.E., Drellich, M.G., & Sutherland, A.M. (1959). The role of hormones in human behavior. I. Changes in female sexuality after adrenalectomy. Journal of Clinical Endocrinology, 19, 193-202.
147. Waxenberg, S.E., Finkbeiner, J.A., Drellich, M.G., & Sutherland, A.M. (1960). The role of hormones in human behavior. Psychosomatic Medicine, 12, 435-442.
148. Weizman, R., Weizman, A., Levi, J., Gura, V., Zevin, D., Maoz, B., Wijsenbeek, H., & David, M.B. (1983). Sexual dysfunction associated with hyperprolactinemia in males and females undergoing hemodialysis. Psychosomatic Medicine, 45, 259-269.
149. Winters, S.J., Kelley, D.E., & Goodpaster, B. (1998). The analog free testosterone assay: Are the results in men clinically useful? Clinical Chemistry, 44, 2178-2182.
150. Young, C.R. (1987). Antiandrogenic treatment in auniversity setting. Journal of American College Health, 35, 277-278.
151. Zilbergeld, B., & Ellison, C.R. (1980). Desire discrepancies and arousal problems in sex therapy. In S. R. Leiblum & L. A. Pervin (Eds.), Principles and Practice of Sex Therapy (pp. 65-101). New York: The Guilford Press.
152. Zwirska-Korczala, K., Ostrowska, Z., Zych, F., & Buntner, B. (1991). The levels of pituitary-testicular axis hormones and SHBG in active acromegaly following bromocriptine treatment. Endocrine Regulations, 25, 211-216.